VACCINE HEALTH: A healthcare market research firm says vaccines are one of the healthiest segments of the pharmaceutical business, with global sales growing 16 percent in 2009, to $22.1 billion.
FUTURE GROWTH: Kalorama Information is forecasting vaccine sales will rise at a compound annual rate of nearly 10 percent during the next five years. That would push sales to roughly $35 billion, nearly double the 2008 level.
SALES DRIVERS: Companies are developing new vaccines and working to increase use of current ones, both in developed and emerging markets. Kids’ shots are leading the way.
Please read our comment policy before commenting.